US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Stage

0.3754

0.0000

Volume:- -

Turnover:- -

Market Cap:10.85M

PE:-0.11

High:0.3754

Open:0.3754

Low:0.3754

Close:0.3754

52wk High:9.50

52wk Low:0.2700

Shares:28.91M

Float Shares:20.31M

Volume Ratio:- -

T/O Rate:- -

Dividend:0.05

Dividend Rate:13.32%

EPS(TTM):-3.3321

EPS(LYR):-3.1264

ROE:-44.60%

ROA:-3.54%

PB:0.07

PE(LYR):-0.12

Loading ...

Overview Company News Filings

BridgeBio: De-Risked Achondroplasia Program and Expanding Late-Stage Rare-Disease Portfolio Underpin Buy Rating and Blockbuster Growth Outlook

Sun Pharma’s GL0034 Diabetes Trial: Early-Stage Data Catalyst in a Crowded Metabolic Market

Tietoevry Calls 2026 AGM and Proposes Two-Stage Dividend of EUR 0.88 per Share

American Airlines Staff To Stage Protest, Demand 'Accountability' After Historic No-Confidence Vote On CEO Robert Isom

Alpha HPA Says Solvent Extraction Tanks Delivered to Site for Queensland Project Stage Two Construction; Shares Fall 3%

MT Newswires Live

GBM Resources Begins Stage Two Drilling Program at Queensland Project, Shares Jump 8%

MT Newswires Live

Bicara moved to Neutral from Early-Stage Biotech at Goldman Sachs

Buy Rating on Gilead: Solid Core Growth, Conservative Guidance, and Late-Stage Pipeline Upside Into 2026

Takeda Advances Oral Crohn’s Disease Drug TAK-279 With Active Mid-Stage Trial

Stoke Therapeutics Initiates Early-Stage Study for Genetic Vision Loss Treatment

MT Newswires Live

Lindian Resources Starts Second-Stage Resource Definition Drilling at Malawi Project

MT Newswires Live

Immatics’ treatment of Stage II and higher CM granted FDA orphan designation

Sally Beauty: Early-Stage Growth Initiatives and Margin Expansion Underpin Buy Rating and Raised $20 Price Target

Nuvation Bio Finalizes Protocol Amendment to Change Safusidenib Study From Mid-Stage to Late-Stage Trial

MT Newswires Live

Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy

Ucommune Shareholders Approve Major Capital Increase and Multi-Stage Reverse Split Plan

Mindarie’s Unconditional Cash Offer Sets Stage for Alpha Integrated REIT Shake-Up

Balanced Risk/Reward for Cloudflare: Strong AI-Driven Strategic Position Tempered by Premium Valuation and Early-Stage Monetization

Actinogen Raises Capital via Institutional Share Placement to Support Late-Stage Trials

Dreadnought Upgrades Mangaroon Gold Results, Sets Stage for Systematic Minga Bar Drilling

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SSI/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SSI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SSI\",,,,,undefined,":{"symbol":"SSI","market":"US","secType":"STK","nameCN":"Stage","latestPrice":0.3754,"timestamp":1588968000000,"preClose":0.3754,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":20307519,"shares":28911336,"eps":-3.332056,"marketStatus":"Halted","change":0,"latestTime":"05-08 16:00:00 EDT","open":0.3754,"high":0.3754,"low":0.3754,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.332056,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773043200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":998884800000,"exchange":"NYSE","adjPreClose":0.3754,"dividendRate":0.133191,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SSI\",,,,,undefined,":{"symbol":"SSI","floatShares":20307519,"roa":"-3.54%","roe":"-44.60%","lyrEps":-3.1264,"shares":28911336,"dividePrice":0.05,"high":0.3754,"amplitude":0,"preClose":0.3754,"low":0.3754,"week52Low":0.27,"pbRate":"0.07","week52High":9.5,"institutionHeld":0.5253,"latestPrice":0.3754,"eps":-3.332056,"divideRate":0.133191,"volume":0,"delay":0,"ttmEps":-3.332056,"open":0.3754,"prevYearClose":8.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SSI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-11-21","symbol":"SSI","fiscalQuarterEnding":"2019/10","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1574312400000,"reportTimeType":"pre","actualEps":-0.15},{"date":"2019-08-22","symbol":"SSI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/07","expectedEps":null,"defaultRemindTime":1566460800000,"name":null,"time":"Pre-Market","dateTimestamp":1566446400000,"actualEps":-0.6},{"market":"US","date":"2019-05-23","symbol":"SSI","fiscalQuarterEnding":"2019/04","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1558584000000,"reportTimeType":"pre","actualEps":-1.67},{"market":"US","date":"2019-03-07","symbol":"SSI","fiscalQuarterEnding":"2019/01","expectedEps":0.73,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1551934800000,"reportTimeType":"pre","actualEps":0.25},{"market":"US","date":"2018-12-03","symbol":"SSI","amount":0.05,"name":"Stage Stores Inc","currency":"USD","type":"dividend","dateTimestamp":1543813200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SSI\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-24","recordDate":null,"paymentDate":null,"value":0.15,"currency":"USD"},{"executeDate":"2017-05-25","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2017-08-25","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2017-11-27","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2018-03-05","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SSI\",market:\"US\",delay:true,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SSI\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611971043","title":"BridgeBio: De-Risked Achondroplasia Program and Expanding Late-Stage Rare-Disease Portfolio Underpin Buy Rating and Blockbuster Growth Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2611971043","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611971043?lang=en_us&edition=fundamental","pubTime":"2026-02-13 03:15","pubTimestamp":1770923719,"startTime":"0","endTime":"0","summary":"Jefferies analyst Andrew Tsai maintained a Buy rating on BridgeBio Pharma today and set a price target of $100.00. Andrew Tsai has given his Buy ra...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/bridgebio-de-risked-achondroplasia-program-and-expanding-late-stage-rare-disease-portfolio-underpin-buy-rating-and-blockbuster-growth-outlook-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/bridgebio-de-risked-achondroplasia-program-and-expanding-late-stage-rare-disease-portfolio-underpin-buy-rating-and-blockbuster-growth-outlook-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2611377975","title":"Sun Pharma’s GL0034 Diabetes Trial: Early-Stage Data Catalyst in a Crowded Metabolic Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2611377975","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611377975?lang=en_us&edition=fundamental","pubTime":"2026-02-13 00:31","pubTimestamp":1770913902,"startTime":"0","endTime":"0","summary":"Sun Pharmaceutical Industries Limited ($IN:SUNPHARMA) announced an update on their ongoing clinical study. Sun Pharmaceutical Industries Ltd. is ru...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sun-pharmas-gl0034-diabetes-trial-early-stage-data-catalyst-in-a-crowded-metabolic-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sun-pharmas-gl0034-diabetes-trial-early-stage-data-catalyst-in-a-crowded-metabolic-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2610924295","title":"Tietoevry Calls 2026 AGM and Proposes Two-Stage Dividend of EUR 0.88 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2610924295","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610924295?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:55","pubTimestamp":1770904543,"startTime":"0","endTime":"0","summary":"TietoEVRY ( ($GB:0KG0) ) has shared an update. Tietoevry has convened its shareholders to the Annual General Meeting, scheduled for 24 March 2026 a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tietoevry-calls-2026-agm-and-proposes-two-stage-dividend-of-eur-0-88-per-share?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tietoevry-calls-2026-agm-and-proposes-two-stage-dividend-of-eur-0-88-per-share?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","AGM","BK4229","BK4195"],"gpt_icon":0},{"id":"2610249229","title":"American Airlines Staff To Stage Protest, Demand 'Accountability' After Historic No-Confidence Vote On CEO Robert Isom","url":"https://stock-news.laohu8.com/highlight/detail?id=2610249229","media":"Benzinga","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610249229?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:41","pubTimestamp":1770903660,"startTime":"0","endTime":"0","summary":"The Association of Professional Flight Attendants (APFA), representing over 28,000 flight attendants of the American Airlines Group (NYSE: AAL), will hold a protest on Thursday, calling for \"accountability and leadership change.\"","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/12/Phoenix--Az---December-7--2019-Photo-Of-.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/12/Phoenix--Az---December-7--2019-Photo-Of-.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/travel/26/02/50574435/american-airlines-staff-to-stage-protest-demand-accountability-after-historic-no-confidence-vote-on-ceo-robert-isom","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/travel/26/02/50574435/american-airlines-staff-to-stage-protest-demand-accountability-after-historic-no-confidence-vote-on-ceo-robert-isom","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4500","BK4547","BK4585","SSI","BK4008","AAL","BK4588"],"gpt_icon":0},{"id":"2610957659","title":"Alpha HPA Says Solvent Extraction Tanks Delivered to Site for Queensland Project Stage Two Construction; Shares Fall 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610957659","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610957659?lang=en_us&edition=fundamental","pubTime":"2026-02-12 09:45","pubTimestamp":1770860757,"startTime":"0","endTime":"0","summary":"Alpha HPA  said solvent extraction tanks were delivered to the site for the construction of stage two of the HPA First project in Queensland, according to a Thursday statement.The solvent extraction circuit is a key part of the design to produce ultra-high-purity aluminum materials.Its shares fell 3% in recent trading on Thursday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["A4N.AU","BK7017","SSI"],"gpt_icon":0},{"id":"2610998251","title":"GBM Resources Begins Stage Two Drilling Program at Queensland Project, Shares Jump 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610998251","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610998251?lang=en_us&edition=fundamental","pubTime":"2026-02-12 08:18","pubTimestamp":1770855535,"startTime":"0","endTime":"0","summary":"GBM Resources  began a multi-rig 50,000-meter stage two drilling program at the Twin Hills project in Queensland, according to a Thursday Australian bourse filing.The program consists of around 20,000 meters of reverse circulation and 30,000 meters of diamond drilling. The drilling will prioritise the definition and expansion of near-surface mineralisation suitable for open-pit mining.Its shares climbed 8% in recent trading on Thursday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GBM.AU","SSI","BK7104"],"gpt_icon":0},{"id":"2610964354","title":"Bicara moved to Neutral from Early-Stage Biotech at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2610964354","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610964354?lang=en_us&edition=fundamental","pubTime":"2026-02-12 05:45","pubTimestamp":1770846337,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Richard Law moved shares of Bicara Therapeutics (BCAX) to Neutral rating and $14 price target from the firm’s Early-Stage Bio...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bicara-moved-to-neutral-from-early-stage-biotech-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bicara-moved-to-neutral-from-early-stage-biotech-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","LABU"],"gpt_icon":0},{"id":"2610521419","title":"Buy Rating on Gilead: Solid Core Growth, Conservative Guidance, and Late-Stage Pipeline Upside Into 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2610521419","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610521419?lang=en_us&edition=fundamental","pubTime":"2026-02-12 00:45","pubTimestamp":1770828321,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Tyler Van Buren maintained a Buy rating on Gilead Sciences today and set a price target of $160.00. Tyler Van Buren has given his ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-on-gilead-solid-core-growth-conservative-guidance-and-late-stage-pipeline-upside-into-2026-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-on-gilead-solid-core-growth-conservative-guidance-and-late-stage-pipeline-upside-into-2026-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2610897952","title":"Takeda Advances Oral Crohn’s Disease Drug TAK-279 With Active Mid-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2610897952","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610897952?lang=en_us&edition=fundamental","pubTime":"2026-02-12 00:31","pubTimestamp":1770827515,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is running a mid-stage study called “A Phase...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-advances-oral-crohns-disease-drug-tak-279-with-active-mid-stage-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-advances-oral-crohns-disease-drug-tak-279-with-active-mid-stage-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","TAK","BK4007"],"gpt_icon":0},{"id":"2610558199","title":"Stoke Therapeutics Initiates Early-Stage Study for Genetic Vision Loss Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2610558199","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610558199?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:12","pubTimestamp":1770819120,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics  said Wednesday that the first patient has received a dose in an early-stage trial of STK-002 for the treatment of Autosomal Dominant Optic Atrophy, an inherited vision loss condition.The open-label study's primary objective will be to evaluate the safety and tolerability of the investigational medicine in patients between the ages of 6 and 55, the company said.Researchers plan to monitor changes in visual function, eye structure, and quality of life as secondary goals of the clinical program, the company added.Stoke Therapeutics said the trial is currently enrolling participants with a confirmed genetic mutation linked to the condition in Germany and the UK, with additional European sites expected to activate in the coming months.The company also said the dose escalation for the initial four groups is expected to continue through this year and into early next year.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["STOK","BK4007","BK4139","LENZ","BK4539","SSI"],"gpt_icon":0},{"id":"2610704086","title":"Lindian Resources Starts Second-Stage Resource Definition Drilling at Malawi Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2610704086","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610704086?lang=en_us&edition=fundamental","pubTime":"2026-02-11 08:14","pubTimestamp":1770768843,"startTime":"0","endTime":"0","summary":"Lindian Resources  started a second-stage resource definition drilling and mine geotechnical program at the Kangankunde project in Malawi to convert up to 40 million tonnes of current inferred mineral resource material to indicated category, according to a Wednesday filing with the Australian bourse.The program covers roughly 3,400 meters of diamond core drilling and 2,700 meters of reverse circulation drilling, with drilling expected to run through April, the filing said.Assay results are expected in May, with an updated resource model planned for June, per the filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LIN.AU","BK7095","SSI"],"gpt_icon":0},{"id":"2610527670","title":"Immatics’ treatment of Stage II and higher CM granted FDA orphan designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2610527670","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610527670?lang=en_us&edition=fundamental","pubTime":"2026-02-11 07:30","pubTimestamp":1770766213,"startTime":"0","endTime":"0","summary":"Immatics (IMTX)’ treatment of Stage II and higher cutaneous melanoma, in human leukocyte antigen-A 02:01-positive patients, was granted FDA orphan ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immatics-treatment-of-stage-ii-and-higher-cm-granted-fda-orphan-designation-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immatics-treatment-of-stage-ii-and-higher-cm-granted-fda-orphan-designation-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CM","BK4139","BK4207","IMTX","SSI"],"gpt_icon":0},{"id":"2610664234","title":"Sally Beauty: Early-Stage Growth Initiatives and Margin Expansion Underpin Buy Rating and Raised $20 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2610664234","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610664234?lang=en_us&edition=fundamental","pubTime":"2026-02-10 19:55","pubTimestamp":1770724532,"startTime":"0","endTime":"0","summary":"Analyst Susan Anderson of Canaccord Genuity maintained a Buy rating on Sally Beauty, boosting the price target to $20.00. Susan Anderson has given ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sally-beauty-early-stage-growth-initiatives-and-margin-expansion-underpin-buy-rating-and-raised-20-price-target-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sally-beauty-early-stage-growth-initiatives-and-margin-expansion-underpin-buy-rating-and-raised-20-price-target-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","SBH"],"gpt_icon":0},{"id":"2610656513","title":"Nuvation Bio Finalizes Protocol Amendment to Change Safusidenib Study From Mid-Stage to Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2610656513","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610656513?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:04","pubTimestamp":1770645869,"startTime":"0","endTime":"0","summary":"Nuvation Bio  said Monday that it has finalized a protocol amendment to upgrade an ongoing study of its cancer drug, safusidenib, from a mid-stage to a late-stage trial.The expanded registrational study now includes patients with high-risk or high-grade IDH1-mutant astrocytoma who have completed standard care, the company said.Participant enrollment for the trial will increase from 100 to 300 patients across the US, China, and Australia, Nuvation Bio said.The updated protocol also introduces a new group to evaluate the treatment in patients with grade 3 IDH1-mutant oligodendroglioma who have not received chemotherapy or radiation, the company said.Shares of the company were up less than 1% in recent Monday premarket activity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NUVB","BK4007","SSI"],"gpt_icon":0},{"id":"2610655338","title":"Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2610655338","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610655338?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:30","pubTimestamp":1770643800,"startTime":"0","endTime":"0","summary":"Outlines clinical and growth catalysts for ONP-002 in concussion and mild traumatic brain injury (mTBI) Fully prepared to initiate near-term clinical site onboarding and first patient dosing in Austra","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/09/3234525/0/en/Oragenics-Targets-Projected-9-Billion-Market-by-Advancing-First-and-Only-Clinical-Stage-Concussion-and-Mild-Traumatic-Brain-Injury-Therapy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDC","BK4139","SSI","OGEN","IND"],"gpt_icon":0},{"id":"2610365823","title":"Ucommune Shareholders Approve Major Capital Increase and Multi-Stage Reverse Split Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2610365823","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610365823?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:57","pubTimestamp":1770641865,"startTime":"0","endTime":"0","summary":"Ucommune International ( ($UK) ) has provided an update. On 9 February 2026, Ucommune International Ltd held an extraordinary general meeting in Be...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ucommune-shareholders-approve-major-capital-increase-and-multi-stage-reverse-split-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ucommune-shareholders-approve-major-capital-increase-and-multi-stage-reverse-split-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2610658765","title":"Mindarie’s Unconditional Cash Offer Sets Stage for Alpha Integrated REIT Shake-Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2610658765","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610658765?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:42","pubTimestamp":1770640936,"startTime":"0","endTime":"0","summary":"Sabana Industrial REIT ( ($SG:M1GU) ) has shared an announcement. Mindarie Investment Pte. Ltd., advised by United Overseas Bank, has launched a ma...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mindaries-unconditional-cash-offer-sets-stage-for-alpha-integrated-reit-shake-up?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mindaries-unconditional-cash-offer-sets-stage-for-alpha-integrated-reit-shake-up?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG","SSI","REIT","BK4209"],"gpt_icon":0},{"id":"2610550428","title":"Balanced Risk/Reward for Cloudflare: Strong AI-Driven Strategic Position Tempered by Premium Valuation and Early-Stage Monetization","url":"https://stock-news.laohu8.com/highlight/detail?id=2610550428","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610550428?lang=en_us&edition=fundamental","pubTime":"2026-02-09 09:45","pubTimestamp":1770601520,"startTime":"0","endTime":"0","summary":"Analyst Shrenik Kothari from Robert W. Baird maintained a Hold rating on Cloudflare and keeping the price target at $230.00. Shrenik Kothari has gi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/balanced-risk-reward-for-cloudflare-strong-ai-driven-strategic-position-tempered-by-premium-valuation-and-early-stage-monetization-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/balanced-risk-reward-for-cloudflare-strong-ai-driven-strategic-position-tempered-by-premium-valuation-and-early-stage-monetization-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","XELB","BK4094"],"gpt_icon":0},{"id":"2610506513","title":"Actinogen Raises Capital via Institutional Share Placement to Support Late-Stage Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2610506513","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610506513?lang=en_us&edition=fundamental","pubTime":"2026-02-09 08:18","pubTimestamp":1770596298,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Actinogen Medical ( ($AU:ACW) ). Actinogen Medical has raised capital by issuing 269,833,333 new fully paid ord...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-raises-capital-via-institutional-share-placement-to-support-late-stage-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-raises-capital-via-institutional-share-placement-to-support-late-stage-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2610150352","title":"Dreadnought Upgrades Mangaroon Gold Results, Sets Stage for Systematic Minga Bar Drilling","url":"https://stock-news.laohu8.com/highlight/detail?id=2610150352","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610150352?lang=en_us&edition=fundamental","pubTime":"2026-02-09 06:08","pubTimestamp":1770588516,"startTime":"0","endTime":"0","summary":"Dreadnought Resources Limited ( ($AU:DRE) ) has issued an update. Dreadnought Resources Ltd is an Australian mineral exploration company focused on...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dreadnought-upgrades-mangaroon-gold-results-sets-stage-for-systematic-minga-bar-drilling?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dreadnought-upgrades-mangaroon-gold-results-sets-stage-for-systematic-minga-bar-drilling?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}